Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281840
Status:
COMPLETED
Last Update Posted:
2015-06-09
First Post:
2006-01-24
Brief Title:
Bevacizumab Docetaxel and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV squamous cell carcinoma of the oropharynx | View |
| stage III squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| stage III squamous cell carcinoma of the larynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| stage III squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| stage III squamous cell carcinoma of the nasopharynx | View |
| stage IV squamous cell carcinoma of the nasopharynx | View |
| stage III squamous cell carcinoma of the oropharynx | View |